Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 20
  • Start Date: January 2021
Phase 4, Single-Arm Study of Ravulizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria Currently Treated With High-Dose Eculizumab
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 200
  • Start Date: December 18, 2020
A Phase 2, Open-Label Study to Evaluate the Long-term Safety of Oral BCX9930 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 60
  • Start Date: October 2020
The Pharmacokinetics and Pharmacodynamics of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 147
  • Start Date: December 3, 2019
An Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of REGN3918 in Patients With Paroxysmal Nocturnal Hemoglobinuria
Showing 1-12 of 42